Medipharm Labs Corp
TSX:LABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
ELGI Rubber Co Ltd
NSE:ELGIRUBCO
|
IN |
Medipharm Labs Corp
Cash from Financing Activities
Medipharm Labs Corp
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medipharm Labs Corp
TSX:LABS
|
Cash from Financing Activities
-CA$18k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash from Financing Activities
-$742m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cash from Financing Activities
CA$269.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
21%
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash from Financing Activities
-$19.9m
|
CAGR 3-Years
-90%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Cash from Financing Activities
$25.2m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash from Financing Activities
CA$5.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
Medipharm Labs Corp
Glance View
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario and currently employs 190 full-time employees. The company went IPO on 2018-02-09. The firm produces purified, pharmaceutical-like cannabis extracts and related derivative products. The firm formulates, processes, packages and distributes cannabis extracts and cannabinoid-based products at its Canadian and Australian facilities for domestic and international markets. The Company, through its subsidiaries is engaged in the sale and distribution of cannabis oil, cannabis extracts, cannabis edibles, cannabis topicals, and derivatives to authorized classes of purchasers, as well as controlled human administration trials for sensory testing of cannabis extracts and derivative products. The company is also engaged in the manufacturing of extracts and tinctures of cannabis and cannabis resin for the purpose of a clinical trial or prescribed as medical cannabis products. The firm's wholly owned subsidiaries include MediPharm Labs Inc. and MediPharm Labs Australia Pty. Ltd.
See Also
What is Medipharm Labs Corp's Cash from Financing Activities?
Cash from Financing Activities
-18k
CAD
Based on the financial report for Dec 31, 2025, Medipharm Labs Corp's Cash from Financing Activities amounts to -18k CAD.
What is Medipharm Labs Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
99%
Over the last year, the Cash from Financing Activities growth was 99%.
